APA (7th ed.) Citation

Vela‐Navarrete, R., Alcaraz, A., Rodríguez‐Antolín, A., Miñana López, B., Fernández‐Gómez, J. M., Angulo, J. C., . . . Ficarra, V. (2018). Efficacy and safety of a hexanic extract of Serenoa repens (Permixon®) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): Systematic review and meta‐analysis of randomised controlled trials and observational studies. BJU International, 122(6), 1049. https://doi.org/10.1111/bju.14362

Chicago Style (17th ed.) Citation

Vela‐Navarrete, Remigio, et al. "Efficacy and Safety of a Hexanic Extract of Serenoa Repens (Permixon®) for the Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia (LUTS/BPH): Systematic Review and Meta‐analysis of Randomised Controlled Trials and Observational Studies." BJU International 122, no. 6 (2018): 1049. https://doi.org/10.1111/bju.14362.

MLA (9th ed.) Citation

Vela‐Navarrete, Remigio, et al. "Efficacy and Safety of a Hexanic Extract of Serenoa Repens (Permixon®) for the Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia (LUTS/BPH): Systematic Review and Meta‐analysis of Randomised Controlled Trials and Observational Studies." BJU International, vol. 122, no. 6, 2018, p. 1049, https://doi.org/10.1111/bju.14362.